TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Archer Materials ( (AU:AXE) ) has issued an update.
Archer Materials is progressing in the development of its Biochip technology with significant improvements in biosensor testing accuracy, aligning with clinical standards. The company is working on both graphene-based and silicon-based biosensor platforms, with the latter expected to facilitate quicker and more cost-effective commercialization, enhancing Archer’s market strategy and IP portfolio.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
More about Archer Materials
Archer Materials Limited is a semiconductor company focused on advancing the quantum technology and medical diagnostics industries.
YTD Price Performance: -52.59%
Average Trading Volume: 288,568
Technical Sentiment Signal: Sell
Current Market Cap: A$70.08M
For an in-depth examination of AXE stock, go to TipRanks’ Overview page.